Altered Phosphatidylcholine Metabolism In Alzheimer?s Disease Found Using UPLC-Q-ToF And NMR Based Metabolomics | 12515
Journal of Alzheimers Disease & Parkinsonism
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Abberant lipid metabolism is implicated in Alzheimer?s disease (AD) pathophysiology, but the connections between AD and
lipid metabolic pathways are not fully understood. To investigate plasma lipids in AD, a multiplatform screen (N=35 by
LC-MS and N=35 by NMR) was developed which enabled the comprehensive analysis of plasma from three groups (AD, MCI
and age matched control). This Metabolomics screen identified three phosphatidylcholine (PC) molecules that were significantly
diminished in AD cases. In a subsequent validation study (N=141), PC variation in a bigger sample set was investigated. These
three PCs were again significantly lower in AD cases: PC 16:0/20:5 (p<0.001), 16:0/22:6 (p<0.05) and 18:0/22:6 (p<0.01). A
receiver operated characteristic (ROC) analysis of the PCs combined with ApoE data produced an area under the curve predictive
value of 0.828. Confirmatory investigations into the background biochemistry indiciated no significant plasma change in three
further PCs of similar structure, total choline containing compounds or three fatty acid side chains, adding to the evidence that
specific PCs play a role in AD pathology.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals